MERCK & CO, INC. for MERCK & CO INC
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trans-Pacific Partnership, data exclusivity for biologics
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
| COURTNEY LEE-ASHLEY | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
Taxation/Internal Revenue Code TAX
Comprehensive tax reform (no specific bill), House Republican tax blueprint, international tax proposals (no specific bill), orphan drug legislation (HR 3678)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
| JENELLE KRISHNAMOORTHY | — |
| COURTNEY LEE-ASHLEY | — |
| ERIN POLAK | — |
Copyright/Patent/Trademark CPT
Patent settlements/pay for delay (general education)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
| JENELLE KRISHNAMOORTHY | — |
| COURTNEY LEE-ASHLEY | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
Health Issues HCR
340B (no specific bill), Hepatitis C (general education; no specific bill), Human papilloma virus and vaccine policies (general education), shingles vaccine policies (general education), antimicrobial resistance (general education and DISARM (H.R. 4187), biosimilars (no specific bill), 21st Century Cures (H.R.6), Senate Innovation Project (no bill number), cost and value of medicines (no specific bill), priority review voucher, biodefense and medical countermeasures (general education), women's health (general education), Prescription Drug User Fee Act (PDUFA; general education), Affordable Care Act, S. 3056 (CREATES Act), risk evaluation and mitigation strategies (general education), general pharmaceutical issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES CAREY | — |
| ERIN DARLING | — |
| ROBERT FILIPPONE | — |
| JENELLE KRISHNAMOORTHY | — |
| COURTNEY LEE-ASHLEY | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
Medicare/Medicaid MMM
Medicare Part D (general education, no specific bill), changes to low-income subsidy structure in Medicare Part D (general education, no specific bill), H.R. 5122 (Centers for Medicare and Medicaid Innovation Part B demo), Independent Payment Advisory Board (general education, no specific bill), Medicare Part B (general education); Medicaid (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN DARLING | — |
| ROBERT FILIPPONE | — |
| JENELLE KRISHNAMOORTHY | — |
| COURTNEY LEE-ASHLEY | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
Animals ANI
Animal health vaccines, FMD vaccine bank, USDA rule for categorical exclusions for animal health vaccines, FDA guidance 209-213, FDA rule regarding species-specific antibiotics data collection, Animal Drug User Fee Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| COURTNEY LEE-ASHLEY | — |
| ERIN POLAK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.